With high prevalence at somatic and germline allele frequencies, the potential driver role of MAP3K9 in idiopathic pCCA warrants clarity given mutations are gain of function in lung cancer41, and loss of function in melanoma wherein its attenuation may lead to chemo-resistance42. This evidence concerns the gene MAP3K9 and progressive cerebello-cerebral atrophy.